Atlas Trials

Study to Explore the Onset of Efficacy on Magnetic Resonance Disease Activity of BG00012 (Dimethyl Fumarate) in Patients With Relapsing remitTing Multiple Sclerosis

Clinical trial NCT02472938 · WITHDRAWN

Trial details

NCT number
NCT02472938
Sponsor
Biogen
Status
WITHDRAWN
Phase
Phase 4
Study type
INTERVENTIONAL
Relapsing Remitting Multiple Sclerosis
Start date
2015-07-01
Primary completion
2019-07-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.